Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cacciaguerra

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Movement Disorders Clinical Practice|September 13, 2024
Family History in Parkinson's Disease: A National Cross-Sectional StudyFederica Arienti, Giovanni Casazza, Giulia Franco, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Neurology|August 29, 2025
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseSmathorn Thakolwiboon, Vyanka Redenbaugh, Bo Chen, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
JAMA Neurology|July 13, 2026
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAndreu Vilaseca, Philippe A Bilodeau, Georgios Gakis, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Movement Disorders Clinical Practice|September 13, 2024
Family History in Parkinson's Disease: A National Cross-Sectional StudyFederica Arienti, Giovanni Casazza, Giulia Franco, et al.
Annals of Neurology|May 23, 2024
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple SclerosisRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Neurology|August 29, 2025
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseSmathorn Thakolwiboon, Vyanka Redenbaugh, Bo Chen, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
JAMA Neurology|July 13, 2026
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAndreu Vilaseca, Philippe A Bilodeau, Georgios Gakis, et al.
Pageof 6